American International Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

American International Group’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,647	Closed	-$866K	–	3080
2023 Q2	$866K	Buy	18,647 +1,566	+9%	+$54.1K	0.01%	1322
2023 Q1	$489K	Buy	17,081 +339	+2%	+$10K	﹤0.01%	1617
2022 Q4	$522K	Buy	16,742 +3,263	+24%	+$106K	﹤0.01%	1564
2022 Q3	$273K	Buy	13,479 +190	+1%	+$3.46K	﹤0.01%	1973
2022 Q2	$206K	Buy	13,289 +6,374	+92%	+$110K	﹤0.01%	2158
2022 Q1	$132K	Sell	6,915 -486	-7%	-$8.67K	﹤0.01%	2473
2021 Q4	$187K	Buy	+7,401	New	+$217K	﹤0.01%	2412

American International Group's DICE Position: Q3 2023 in Review

American International Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 18,647 shares — an estimated $866K sold.

American International Group first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $866K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

American International Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
American International Group sold 18,647 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $866K.
American International Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
American International Group's DICE Therapeutics, Inc. Common Stock position peaked at $866K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on American International Group's 13F filing for Q3 2023, filed 13 Nov 2023.